Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer
{{output}}
Prostate cancer (PCa) is the most common cancer and second leading cause of cancer death in American men. Most patients with metastatic disease respond initially to androgen deprivation therapy (ADT), but almost inevitably progress to castration resistant pros... ...